Biohaven (BHVN) Income from Continuing Operations (2021 - 2026)

Biohaven's (BHVN) quarterly Income from Continuing Operations came in at 130532000.0 in Q1 2026, up 41.12% year-on-year from 92499703.23 in Q1 2025, and up 10.32% quarter-over-quarter from 145555000.0 in Q4 2025.

Biohaven (BHVN) Income from Continuing Operations (2021 - 2026) Analysis & Trends

Biohaven has disclosed Income from Continuing Operations across 6 years of filings, most recently posting 130532000.0 for Q1 2026.

  • Income from Continuing Operations for Q1 2026 came in at 130532000.0, up 41.12% year-over-year; the trailing twelve-month figure through Mar 2026 was 647677000.0 (up 27.11% YoY), and the FY2025 annual result was 738822000.0, up 12.71% from the prior year.
  • Income from Continuing Operations came in at 130532000.0 for Q1 2026 at Biohaven, up from 145555000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 68853000.0 in Q3 2022 to a low of 319771000.0 in Q2 2024.
  • The 5-year median for Income from Continuing Operations is 160304000.0 (2024), against an average of 158483705.88.
  • Across the five-year window, Income from Continuing Operations slumped 287.59% in 2022 and soared 55.56% in 2023, its largest moves.
  • Biohaven's Income from Continuing Operations stood at 201107000.0 in 2022, then advanced by 28.02% to 144756000.0 in 2023, then retreated by 29.07% to 186843000.0 in 2024, then climbed by 22.1% to 145555000.0 in 2025, then climbed by 10.32% to 130532000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 130532000.0 (Q1 2026), 145555000.0 (Q4 2025), and 173443000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -2.97 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 30.80 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -14.46 Mn
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -3.40 Mn
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 1.03 Bn
9 Abivax 91.71 Bn 91.71 Bn - -56.48 Mn
10 Biohaven 1.62 Bn 1.27 Bn - -130.53 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -130.53 Mn
Dec 31, 2025 -145.56 Mn
Sep 30, 2025 -173.44 Mn
Jun 30, 2025 -198.15 Mn
Mar 31, 2025 -221.68 Mn
Dec 31, 2024 -186.84 Mn
Sep 30, 2024 -160.30 Mn
Jun 30, 2024 -319.77 Mn
Mar 31, 2024 -179.50 Mn
Dec 31, 2023 -144.76 Mn
Sep 30, 2023 -102.57 Mn
Jun 30, 2023 -90.35 Mn
Mar 31, 2023 -70.49 Mn
Dec 31, 2022 -201.11 Mn
Sep 30, 2022 -68.85 Mn
Jun 30, 2022 -203.29 Mn
Mar 31, 2022 -97.03 Mn
Dec 31, 2021 -51.89 Mn
Sep 30, 2021 -54.37 Mn